TD Cowen analyst Kyle Boucher downgraded Bio-Techne Corp. (NASDAQ: TECH) from Buy to Hold with a price target of $73.00.

For an analyst ratings summary and ratings history on Bio-Techne Corp. click here. For more ratings news on Bio-Techne Corp. click here.

Shares of Bio-Techne Corp. closed at $71.00 yesterday.